Zobrazeno 1 - 10
of 42
pro vyhledávání: '"J. H. Barton"'
Autor:
J. H. Barton, David R. Spigel, Chris Earwood, Johanna C. Bendell, Lowell L. Hart, Cassie M. Lane, Howard A. Burris, Suzanne F. Jones, Jeffrey R. Infante
Publikováno v:
Investigational New Drugs. 33:187-193
To determine the maximum tolerated dose (MTD) of the combination of linsitinib (OSI-906), a dual inhibitor of IGFR and IR tyrosine kinase activity, and everolimus as treatment for patients with refractory metastatic colorectal cancer (mCRC). Eligible
Autor:
J. H. Barton, Patrick Murphy, Johanna C. Bendell, Gregg C. Shepard, Noel A. Maun, Laura Blakely, Mark Mainwaring, Edward Arrowsmith, James D. Peyton
Publikováno v:
The Oncologist
Lessons Learned Neoadjuvant 5-fluorouracil, oxaliplatin, and lapatinib in combination with radiation therapy is safe for neoadjuvant treatment for patients with localized human epidermal growth receptor 2-positive esophagogastric adenocarcinoma. Eval
Publikováno v:
Intellectual Property Rights Associated with Plants
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::449bef411a0cdc6520235b59e3e6de77
https://doi.org/10.2134/asaspecpub52.appendix3
https://doi.org/10.2134/asaspecpub52.appendix3
Publikováno v:
Intellectual Property Rights Associated with Plants
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3c233ab207c20d3b6e57f94bb51746d6
https://doi.org/10.2134/asaspecpub52.c19
https://doi.org/10.2134/asaspecpub52.c19
Publikováno v:
Intellectual Property Rights Associated with Plants
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6e870001127b744d2ee88400a8e26fca
https://doi.org/10.2134/asaspecpub52.c16
https://doi.org/10.2134/asaspecpub52.c16
Publikováno v:
Intellectual Property Rights Associated with Plants
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::00aea88ae7e608729731b7ff5d650ec6
https://doi.org/10.2134/asaspecpub52.appendix4
https://doi.org/10.2134/asaspecpub52.appendix4
Publikováno v:
Intellectual Property Rights Associated with Plants
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::153019f3c70037cddffaa4bb8ab8b00e
https://doi.org/10.2134/asaspecpub52.appendix2
https://doi.org/10.2134/asaspecpub52.appendix2
Publikováno v:
Intellectual Property Rights Associated with Plants
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e6d39f20121a9b4d18b53f463f18e9cf
https://doi.org/10.2134/asaspecpub52.appendix1
https://doi.org/10.2134/asaspecpub52.appendix1
Autor:
F. Anthony Greco, Sarah Hanson, J. H. Barton, David R. Spigel, Howard A. Burris, John D. Hainsworth, Denise A. Yardley
Publikováno v:
Clinical Breast Cancer. 9:178-183
Background The use of trastuzumab in combination with either a taxane or vinorelbine has improved the efficacy of treatment for women with HER2-positive (HER+) breast cancer. We investigated the activity and toxicity of the gemcitabine/trastuzumab co
Autor:
F. Anthony Greco, J. H. Barton, David R. Spigel, Howard A. Burris, Dianna Shipley, David Drosick, Denise A. Yardley, L. Simons, John D. Hainsworth
Publikováno v:
Clinical Breast Cancer. 8:425-431
Purpose The purpose of this study was to evaluate the efficacy and toxicity of the combination of gemcitabine and carboplatin (and with trastuzumab in patients with HER2-positive disease) as first-line treatment for patients with metastatic breast ca